These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4645581)

  • 21. [Tests of reversibility of bronchial obstruction].
    Meslier N; Racineux JL; Grandordy B
    Rev Mal Respir; 1986; 3(6):355-60. PubMed ID: 3575855
    [No Abstract]   [Full Text] [Related]  

  • 22. [Nebulizer in treatment of chronic obstructive lung diseases].
    Khmel'kova NG; Melent'eva EM
    Ter Arkh; 2000; 72(3):50-5. PubMed ID: 10776655
    [No Abstract]   [Full Text] [Related]  

  • 23. Can we lower airway hyperresponsiveness?
    Simonsson BG
    Pneumonol Pol; 1988 Oct; 56(10):447-50. PubMed ID: 3254506
    [No Abstract]   [Full Text] [Related]  

  • 24. Are anticholinergics first choice bronchodilators in the treatment of stable chronic obstructive pulmonary disease?
    Nava S
    Monaldi Arch Chest Dis; 2000 Apr; 55(2):168-9. PubMed ID: 10949881
    [No Abstract]   [Full Text] [Related]  

  • 25. [Bronchodilator nebulization in bronchial obstructions].
    Muir JF; Cuvelier A
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S41-3. PubMed ID: 10088238
    [No Abstract]   [Full Text] [Related]  

  • 26. [The treatment of obstructive airway diseases. I].
    Breithaupt H; Knorpp K
    Med Welt; 1978 Mar; 29(13):505-8. PubMed ID: 634109
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of stable chronic obstructive lung disease with inhaled corticosteroid].
    Vestbo J; Lange P
    Ugeskr Laeger; 2000 Jan; 162(4):520-3. PubMed ID: 10697457
    [No Abstract]   [Full Text] [Related]  

  • 28. Should the FVC be considered in evaluating response to bronchodilator?
    Girard WM; Light RW
    Chest; 1983 Jul; 84(1):87-9. PubMed ID: 6861550
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-agonists, beta-blockers and obstructive airway disease.
    Madalena Esteves M
    Eur Ann Allergy Clin Immunol; 2005 Dec; 37(10):375-9. PubMed ID: 16528900
    [No Abstract]   [Full Text] [Related]  

  • 30. Indications for continuous aerosol therapy.
    Stiksa G
    Eur J Respir Dis Suppl; 1982; 119():89-96. PubMed ID: 7047189
    [No Abstract]   [Full Text] [Related]  

  • 31. Bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airway disease.
    Hahn DL
    N Engl J Med; 1993 Apr; 328(14):1044; author reply 1044-5. PubMed ID: 8450868
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacological perspectives].
    Fournier M; Guérin JC
    Rev Mal Respir; 1998 Sep; 15 Suppl 2():S64-5. PubMed ID: 9809350
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hemodynamic effects of commonly used bronchodilators in cases of bronchial asthma and the obstructive syndrome].
    Schilling W
    Gruzlica; 1971 Jul; 39(7):627-35. PubMed ID: 5117142
    [No Abstract]   [Full Text] [Related]  

  • 34. [The hypersensitive bronchial system. Significance for prognosis inhibition of progression of chronic obstructive respiratory tract diseases].
    Nowak D; Magnussen H
    Internist (Berl); 1993 Apr; 34(4):294-9. PubMed ID: 8486472
    [No Abstract]   [Full Text] [Related]  

  • 35. [Frequent errors in the therapy of chronic obstructive airway diseases].
    Schmidt OP
    Prax Klin Pneumol; 1984 Aug; 38(8):329-38. PubMed ID: 6435114
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of delayed-action beta-2 mimetics in the management of chronic obstructive bronchial diseases--for].
    Muir JF; Cuvelier A
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S75-6. PubMed ID: 10088257
    [No Abstract]   [Full Text] [Related]  

  • 37. [Re: Barandun J: Inhalation therapy in chronic obstructive bronchial diseases. Schweiz Med Wochenschr 1996; 126: 1693-1703].
    Kochen MM
    Schweiz Med Wochenschr; 1997 Mar; 127(10):411. PubMed ID: 9132930
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of inhalation of an atropine derivative (SCH 1000) on airway resistance to flow and on specific conductance in patients with chronic obstructive bronchopneumopathy].
    Anastasatu C; Duţu S
    Ftiziologia; 1974 May; 23(3):305-10. PubMed ID: 4842470
    [No Abstract]   [Full Text] [Related]  

  • 39. A new bronchodilator, hexoprenaline, in obstructive pulmonary disease.
    van As A; Benjamin C; Stern JD
    Scand J Respir Dis; 1973; 54(1):28-37. PubMed ID: 4690403
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of delayed-action beta-2 mimetics in the management of chronic obstructive bronchial disease--against].
    Terrioux P
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S76-7. PubMed ID: 10088258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.